Camber Pharmaceuticals Inc.: Drug Recall
Recall #D-0567-2023 · 03/13/2023
Class I: Dangerous
Recall Details
- Recall Number
- D-0567-2023
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Camber Pharmaceuticals Inc.
- Status
- Ongoing
- Date Initiated
- 03/13/2023
- Location
- Piscataway, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1568 bottles
Reason for Recall
Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
Product Description
Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured by: Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC# 31722-629-21.
Distribution Pattern
Nationwide in the USA
Other Recalls by Camber Pharmaceuticals Inc.
- Class III: Low Risk 12/06/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.